Navigation Links
Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels
Date:9/15/2008

low that it can cause symptoms such as fainting), and are similar to pre-mixed human insulin preparations in terms of the frequency of hypoglycemia reported.

-- Pre-mixed insulin analogues are associated with a higher frequency of hypoglycemic events than oral antidiabetic (non-insulin) agents are.

The report, Comparative Effectiveness, Safety and Indications of Pre-mixed Insulin Analogues for Adults With Type 2 Diabetes, is available at effectivehealthcare.ahrq.gov. It is the newest analysis from AHRQ's Effective Health Care Program, authorized by Section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. That program supports important federal efforts to comparing alternative treatments for health conditions while making the findings public. The program is intended to help patients, doctors, nurses, and others choose the most effective treatments.


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
2. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
7. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
8. Treatment Corrects Severe Insulin Imbalance in Animal Studies
9. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
10. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
11. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...FIELD HILLS, Mich., Nov. 30 eHealt...e dedicated exclusively to products approved for F... (FSA/HSA) claims. The site is also the first to ...dications, saving shoppers up to 75 percent on eve...s cure two common healthcare headaches - high cost...
(Date:11/30/2009)...O, Nov. 30 Dr. Jocelyn Rapelyea, A...on at George Washington University Medical Center ...ns identified with Breast-Specific Gamma Imaging (...aging for needle biopsy as well, as for pre-operat...e Radiological Society of North America (RSNA). ,...
(Date:11/30/2009)...AGO, Nov. 30 MedPro Imaging, a pre...lutions, will showcase leading ultrasound solution...Siemens X300 Premium Edition during the company,s ...ca (RSNA) conference, being held in Chicago Novemb...maging markets ultrasound products and services in...
Breaking Medicine Technology:eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Novel handheld device detects anthrax with outstanding accuracy and reliability 12945 1Novel handheld device detects anthrax with outstanding accuracy and reliability 12945 2Novel handheld device detects anthrax with outstanding accuracy and reliability 12945 3Research shows that invisible hand guides evolution of cooperative turn taking 9182 1Research shows that invisible hand guides evolution of cooperative turn taking 9182 2Upcoming Beckman Coulter Investor Events Second Half of 2009 51160 1Upcoming Beckman Coulter Investor Events Second Half of 2009 51160 2Upcoming Beckman Coulter Investor Events Second Half of 2009 51160 3
...on Study in Patients with,Chronic Decompensated He...ardiology 56th Annual Scientific Session --, MOUNT...PRNewswire/ -- Scios Inc. announced today that an ...ide (NATRECOR(R)) showed a,neutral effect on the p...nal hospitalization at 12 weeks, and provides impo...
...ire/ -- A large patient,registry of "real world" u...tent reported favorable safety and efficacy outcom...vestigators at the of,Cardiology,s 56th Annual Sci... a prospective, single-arm study designed,to evalu...tion (PCI,or balloon angioplasty) with the CYPHER(...
Other Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 2Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 3Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 4
(Date:12/1/2009)...re/ -- "The patient will see you now." That is the...ue Shield of Minnesota,s 10,000 employees and fami... and the first in the continental U.S. - to have a...where allows patients to access medical care from ...picking up the phone. Blue Cross is partnering wit...
(Date:12/1/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (... the 21st Annual Piper Jaffray Health Care Confere...ime will be webcast live at www.celltherapeutics....Holmes 1 at the New York Palace Hotel, and will al... , , Piper Jaffray Health Ca...
(Date:12/1/2009)...mammography screening may increase breast cancer r...on to breast cancer, according to a study presente...Society of North America (RSNA). , "For women a...mportant, but a careful approach should be taken w...men, particularly under age 30," said Marijke C. J...
(Date:12/1/2009)...elastography can help differentiate between cancer...dy presented today at the annual meeting of the Ra...igh-frequency ultrasound with elastography has the...r diagnosis," said lead author Eliot L. Siegel, M....t the University of Maryland School of Medicine (U...
(Date:12/1/2009)...lled clinical trial presented today at the annual ...ca (RSNA) reveal that one in five patients with na...to the legs and other parts of the body also have ..., Peripheral arterial disease (PAD) occurs when p... substances, builds up in the arteries, limiting t...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3Health News:Mammography may increase breast cancer risk in some high-risk women 2Health News:Special ultrasound accurately identifies skin cancer 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2
...t Coast-based Foster Farms Reaffirms Commitment to..., , LIVINGSTON, Calif., March 30 As leaders from...day at an Institute of Medicine meeting to explore...sh chicken and reassuring consumers that the famil...
...ING, Texas, March 30 Patients undergoing cancer t...el significantly reduced the pain and itching asso...d by anti-cancer drugs. , , Conducted by the Wes...ieving and wound-healing benefits. Manufactured by...
...vey Shows More than Half of Americans Still Avoid ...0 Fear of the dentist plagues more than 80 percen...may keep them from going to see the dentist, accor...ing the issue head on as part of its third annual ...
... CREWE, England, March 30 Folding carton speciali... has announced details of its first,move into the ...a Gallus,EM340S printing press with a Scantech Vis...mand as being the key driving factor behind,the mo...
...pany Reports Record Level Revenues - up 44% Over P...stCall/ - Response Biomedical Corporation (TSX: RB...evenues of $5,876,337 and a net loss of $13,663,65....9 million in working capital. For a further discu...
...ancements maximize and automate physician practice...n financial edge during economic downturn , , DA...ng developer of healthcare software solutions for ...,s award-winning Electronic Health Record (EHR) an...
Other Medicine News:Health News:Salt Takes Center Stage in Chicken Producer's New Consumer Campaign 2Health News:Patients Say MPM Medical's Regenecare Gel Significantly Reduced the Itching and Pain of Skin Rashes Triggered by Anti-Cancer Drugs 2Health News:Patients Say MPM Medical's Regenecare Gel Significantly Reduced the Itching and Pain of Skin Rashes Triggered by Anti-Cancer Drugs 3Health News:Getting to the Root of Dental Phobia 2Health News:Getting to the Root of Dental Phobia 3Health News:Getting to the Root of Dental Phobia 4Health News:Benson Group Moves into Pharma Labels Sector 2Health News:Benson Group Moves into Pharma Labels Sector 3Health News:Response Biomedical Corporation Reports 2008 Financial Results 2Health News:Response Biomedical Corporation Reports 2008 Financial Results 3Health News:Response Biomedical Corporation Reports 2008 Financial Results 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 5Health News:iMedica Corporation Announces the Release of Patient Relationship Manager 2009 2Health News:iMedica Corporation Announces the Release of Patient Relationship Manager 2009 3
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: